u/kian_balogun

jurisdiction countries have different thresholds

Did you get step therapy or outright denial?

Not convinced. The evidence does not support that reading.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

Yeah, the incretin mechanism is doing the work here.

the 10-day half-life means week 10 is still ramp-up pharmacokinetically

special auth turnaround is province-specific

Strongly agree. Provincial variation is real.

That is net peptide content, not purity. Different number, different meaning.

redact member ids and group numbers from every screenshot

the customs status depends on what happens at the border

Adding to this: jurisdiction is doing more work than the comment implies.

the personal import status depends on what happens at the border

Disagree. What you are describing is consistent with pharmacology, not with what you concluded.

Disagree but this is the good kind of wrong — it is specific enough to be checked.

do not extrapolate rodent data to human dosing without saying so

That is net peptide content, not purity. Different number, different meaning.

Denied for prior auth, resubmitted with external review documentation, approved on appeal. The criteria exist, you just have to meet them.

glucagon-receptor contribution is mechanism for dual and triple agonism